Pol Arch Intern Med. 2018 Mar 29;128(3):157-165. doi: 10.20452/pamw.4201. Epub 2018 Feb 6.
INTRODUCTION Medial arterial calcification is common in patients with chronic kidney disease (CKD) and is considered a risk factor for morbidity and mortality. OBJECTIVES We aimed to evaluate the correlation between asymmetric dimethylarginine (ADMA) levels, radial artery calcification, and common carotid artery intima-media thickness (CCA‑IMT). PATIENTS AND METHODS The study included 51 patients with CKD, in whom an arteriovenous fistula for hemodialysis access was created to collect radial artery samples for a histological examination, and 33 healthy volunteers, in whom the reference concentrations of ADMA were assessed. The concentrations of creatinine, albumin, calcium, phosphate, fibroblast growth factor 23, osteoprotegerin (OPG), osteopontin (OPN), osteocalcin, secreted protein acidic and rich in cysteine, interleukin 6, interleukin 18, pentraxin 3, stromal cell‑derived factor 1α (SDF1α), thrombomodulin, soluble tumor necrosis factor receptor II (sTNFRII), and matrix metalloproteinase 2 (MMP‑2) were determined. Radial artery fragments were stained for calcifications using alizarin red. The CCA‑IMT was assessed by ultrasonography. RESULTS Patients with CKD had higher ADMA levels than controls. Patients with ADMA levels above the median were older, had higher levels of phosphate, fibroblast growth factor 23, OPG, OPN, PTX3, sTNFRII, MMP‑2, thrombomodulin, and they had more atherosclerotic plaques in the carotid artery. In multiple regression, log‑transformed (log)sTNFRII, MMP‑2, and SDF1α levels were independent predictors of log(ADMA). Patients with calcifications had higher ADMA levels. A similar correlation was observed between SDF1α and alizarin red staining grades 1 to 3. In logistic regression, ADMA levels positively predicted the presence of calcifications independently of age, hemodialysis status, Framingham risk score, and PTX3. CONCLUSIONS Circulating ADMA levels indicate medial arterial calcification in patients with CKD.
动脉钙化在慢性肾脏病(CKD)患者中很常见,被认为是发病率和死亡率的一个危险因素。 目的: 我们旨在评估不对称二甲基精氨酸(ADMA)水平、桡动脉钙化和颈总动脉内膜-中层厚度(CCA-IMT)之间的相关性。 患者和方法: 该研究纳入了 51 例 CKD 患者,为建立血液透析通路,在这些患者中创建动静脉瘘以便采集桡动脉样本进行组织学检查,同时纳入了 33 名健康志愿者,以评估 ADMA 的参考浓度。检测了肌酐、白蛋白、钙、磷、成纤维细胞生长因子 23、护骨素(OPG)、骨桥蛋白(OPN)、骨钙素、富含半胱氨酸的酸性分泌蛋白、白细胞介素 6、白细胞介素 18、Pentraxin 3、基质细胞衍生因子 1α(SDF1α)、血栓调节蛋白、可溶性肿瘤坏死因子受体 II(sTNFRII)和基质金属蛋白酶 2(MMP-2)的浓度。用茜素红对桡动脉碎片进行钙化染色。通过超声评估 CCA-IMT。 结果: CKD 患者的 ADMA 水平高于对照组。ADMA 水平高于中位数的患者年龄较大,磷酸盐、成纤维细胞生长因子 23、OPG、OPN、PTX3、sTNFRII、MMP-2、血栓调节蛋白水平较高,颈动脉有更多的粥样斑块。在多元回归中,log 转化(log)sTNFRII、MMP-2 和 SDF1α 水平是 log(ADMA)的独立预测因子。有钙化的患者 ADMA 水平较高。SDF1α 与茜素红染色 1 至 3 级之间也存在类似的相关性。在逻辑回归中,ADMA 水平独立于年龄、血液透析状态、Framingham 风险评分和 PTX3 预测钙化的存在。 结论: 循环 ADMA 水平提示 CKD 患者的动脉中层钙化。